IS2073B - Staðbundnir úðar sem innihalda himnumyndandi blöndu - Google Patents

Staðbundnir úðar sem innihalda himnumyndandi blöndu

Info

Publication number
IS2073B
IS2073B IS6035A IS6035A IS2073B IS 2073 B IS2073 B IS 2073B IS 6035 A IS6035 A IS 6035A IS 6035 A IS6035 A IS 6035A IS 2073 B IS2073 B IS 2073B
Authority
IS
Iceland
Prior art keywords
composition
mixture
membranous
sprays containing
propellant
Prior art date
Application number
IS6035A
Other languages
English (en)
Other versions
IS6035A (is
Inventor
Lulla Amar
Malhotra Geena
Raut Preeti
Original Assignee
Cipla Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IN93BO1999 external-priority patent/IN186668B/en
Application filed by Cipla Limited filed Critical Cipla Limited
Publication of IS6035A publication Critical patent/IS6035A/is
Publication of IS2073B publication Critical patent/IS2073B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
IS6035A 1999-02-05 2001-08-02 Staðbundnir úðar sem innihalda himnumyndandi blöndu IS2073B (is)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
IN92BO1999 1999-02-05
IN93BO1999 IN186668B (is) 1999-02-05 1999-02-05
IN382BO1999 1999-05-20
IN582BO1999 1999-08-17
GB9902998 1999-09-09
IN44BO2000 2000-01-13
IN43BO2000 2000-01-13
PCT/GB2000/000366 WO2000045795A2 (en) 1999-02-05 2000-02-07 Topical sprays comprising a film forming composition

Publications (2)

Publication Number Publication Date
IS6035A IS6035A (is) 2001-08-02
IS2073B true IS2073B (is) 2005-12-15

Family

ID=27562960

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6035A IS2073B (is) 1999-02-05 2001-08-02 Staðbundnir úðar sem innihalda himnumyndandi blöndu

Country Status (21)

Country Link
EP (1) EP1150661B1 (is)
JP (1) JP2002536319A (is)
AT (1) ATE252380T1 (is)
AU (1) AU759515B2 (is)
BR (1) BR0007997A (is)
CA (1) CA2359640C (is)
DE (1) DE60006069T2 (is)
DK (1) DK1150661T3 (is)
ES (1) ES2209812T3 (is)
HK (1) HK1042043B (is)
HU (1) HUP0105336A3 (is)
ID (1) ID30353A (is)
IL (2) IL144729A0 (is)
IS (1) IS2073B (is)
NO (1) NO329474B1 (is)
NZ (1) NZ513208A (is)
PL (1) PL196413B1 (is)
PT (1) PT1150661E (is)
RO (1) RO121628B1 (is)
WO (1) WO2000045795A2 (is)
ZA (1) ZA200005727B (is)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6524623B1 (en) * 1999-11-12 2003-02-25 Milton Hodosh Therapeutic compositions and methods of use thereof
PL205279B1 (pl) * 2000-08-30 2010-03-31 Besins International Lab Zastosowanie żelu hydroalkoholowego zawierającego testosteron i zestaw do leczenia zaburzenia erekcji
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
IT1319210B1 (it) * 2000-10-13 2003-09-26 Italiano Biochimico Lisapharma Pellicola per la somministrazione dermica e transdermica di principiattivi.
ITMI20012827A1 (it) * 2001-12-28 2003-06-28 Fidia Farmaceutici Formulazioni adesive transdermiche di diclofenac sodico
US7820197B2 (en) 2002-02-14 2010-10-26 Astellas Pharma Inc. Percutaneous preparations
AU2003238543B2 (en) * 2002-06-25 2008-02-28 Acrux Dds Pty Ltd Transdermal aerosol compositions
EA009024B1 (ru) * 2002-06-25 2007-10-26 АКРУКС ДиДиЭс ПиТиУай ЭлТиДи Фармацевтическая композиция для чрескожной доставки активного агента (варианты)
AUPS317302A0 (en) * 2002-06-25 2002-07-18 Drug Delivery Solutions Pty Ltd Metastable pharmaceutical compositions
AU2003240299B2 (en) * 2002-06-25 2008-01-31 Acrux Dds Pty. Ltd. Metastable pharmaceutical compositions
AUPS317102A0 (en) * 2002-06-25 2002-07-18 Drug Delivery Solutions Pty Ltd Transdermal aerosol compositions
AU2002950506A0 (en) * 2002-07-31 2002-09-12 Soltec Research Pty Ltd Percutaneous delivery system
US6986884B2 (en) * 2002-09-04 2006-01-17 Rosenberg E William Composition and method for treating soft nails
WO2004056363A2 (en) 2002-12-20 2004-07-08 Niconovum Ab A physically and chemically stable nicotine-containing particulate material
WO2004071533A1 (ja) * 2003-02-14 2004-08-26 Takeda Pharmaceutical Company Limited 局所投与用製剤
IL155666A (en) * 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
DE10338174A1 (de) 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
ZA200604036B (en) * 2003-10-23 2007-09-26 Cipla Ltd Transdermal pharmaceutical spray formulations comprising a VP/VA copolymer and a non-aqueous vehicle
DE102004009904A1 (de) * 2004-02-26 2005-09-22 Grünenthal GmbH Kit aus einem gegebenenfalls wirkstoffhaltigen Pflaster und einem Hautirritationen verhindernden Mittel
CN102091079B (zh) 2005-06-03 2014-03-12 艾克若克斯Dds有限公司 用于透皮给药的方法和组合物
EP1749528A1 (en) 2005-08-05 2007-02-07 Pharma C S.A. Pharmaceutical combinations containing a mu opioid agonist and an inhibitor of NO production
GB0518769D0 (en) 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations
US9393218B2 (en) 2005-12-23 2016-07-19 Epinamics Gmbh Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers
EP1800671A1 (de) 2005-12-23 2007-06-27 Bayer Schering Pharma Aktiengesellschaft Verwendung filmbildender Haarpflegepolymere und diese Polymere enthaltenden pharmazeutischen Zubereitungen und Pflaster
EP1998748B1 (en) 2006-03-16 2015-01-14 NicoNovum AB Improved snuff composition
US7786055B2 (en) * 2006-04-13 2010-08-31 Mcneil-Ppc, Inc. Antioxidant compositions for reducing odor in warming lubricant compositions
CA2649895C (en) * 2006-04-19 2013-03-26 Novadel Pharma Inc. Stable hydroalcoholic oral spray formulations and methods
US20080075779A1 (en) * 2006-09-27 2008-03-27 Chappa Ralph A Additives And Methods For Enhancing Active Agent Elution Kinetics
KR101301116B1 (ko) 2007-01-11 2013-09-03 애크럭스 디디에스 피티와이 리미티드 분산 기구
WO2008128280A1 (en) * 2007-04-20 2008-10-30 Acrux Dds Pty Ltd Method and system for transdermal administration of volatile active
ES2494853T3 (es) 2007-11-02 2014-09-16 Acrux Dds Pty Ltd Sistema de administración transdérmica
EP2282777A1 (en) * 2008-04-16 2011-02-16 Cipla Limited Topical combinations comprising an antimycotic agent and an antiviral agent
DE102008060904A1 (de) * 2008-12-09 2010-06-10 Beiersdorf Ag Wasserlösliche Wirkstoffe in Sprühpflaster
WO2011061155A1 (en) 2009-11-17 2011-05-26 Bayer Consumer Care Ag Antifungal formulations and their use
CN102018671B (zh) * 2011-01-05 2012-07-25 浙江大学 一种雌二醇透皮喷雾剂及其制备方法
EP3936133A1 (en) 2011-11-23 2022-01-12 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9345774B2 (en) * 2012-07-06 2016-05-24 Leo Pharma A/S Topical composition comprising a film-forming polymer for delivering an active ingredient to skin
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20160250378A1 (en) * 2013-10-21 2016-09-01 Advanced First Aid Research Pte. Ltd. Spray-On Burn Dressing
USD750788S1 (en) 2013-11-26 2016-03-01 Acrux Dds Pty Ltd Topical spreading applicator
USD749225S1 (en) 2013-11-26 2016-02-09 Acrux Dds Pty Ltd Topical spreading applicator
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CN107613987A (zh) * 2015-03-31 2018-01-19 雷迪博士实验室有限公司 糠酸莫米松的局部喷雾组合物
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
ES2901481T3 (es) * 2015-11-23 2022-03-22 Nortic Holdings Inc Pulverización filmógena tópica
BR112018070199A2 (pt) 2016-04-01 2019-01-29 Therapeuticsmd Inc composição farmacêutica de hormônio esteroide
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US11523994B2 (en) * 2018-01-10 2022-12-13 Celista Pharmaceuticals Llc Testosterone transdermal spray with film
WO2019186440A1 (en) * 2018-03-30 2019-10-03 Dr. Reddy's Laboratories Limited Topical pharmaceutical compositions of nimesulide
WO2020161771A1 (ja) * 2019-02-04 2020-08-13 マルホ株式会社 皮膚用組成物
CN116392460A (zh) * 2023-04-18 2023-07-07 山东京卫制药有限公司 一种沙丁胺醇气雾剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3045915A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3612305A1 (de) * 1986-04-11 1987-10-22 Roehm Pharma Gmbh Fluessige arzneiform zur therapie der psoriasis auf basis filmbildender polymere
EP0319555B1 (de) * 1987-05-27 1992-01-29 Kurt Dr. Burghart Transdermal therapeutisch wirkende pharmazeutische zubereitung sowie vorrichtung zum aufbringen der zubereitung
JPH01230514A (ja) * 1987-11-25 1989-09-14 Osaka Aerosol Ind Corp エアゾール型外用貼付剤
JPH0794378B2 (ja) * 1989-08-18 1995-10-11 久光製薬株式会社 エアゾール剤
IL95952A0 (en) * 1989-10-19 1991-07-18 Sterling Drug Inc Aerosol composition for topical medicament
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
FR2664815B1 (fr) * 1990-07-23 1994-11-04 Adir Systeme matriciel autoadhesif pour la liberation prolongee du piribedil par voie transcutanee.
TW247878B (is) * 1991-07-02 1995-05-21 Takeda Pharm Industry Co Ltd
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
GB9408545D0 (en) * 1994-04-29 1994-06-22 Zyma Sa Compositions
FR2732223B1 (fr) * 1995-03-30 1997-06-13 Sanofi Sa Composition pharmaceutique pour administration transdermique
US6060547A (en) * 1995-04-28 2000-05-09 The Proctor & Gamble Company Film forming foundation
IT1277430B1 (it) * 1995-08-03 1997-11-10 Bayer Italia Spa Preparazioni farmaceutiche per uso topico a base di ketoprofene
KR970064620A (ko) * 1996-03-05 1997-10-13 임성기 사이클로스포린-함유 외용약제 조성물
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan

Also Published As

Publication number Publication date
NZ513208A (en) 2003-05-30
ZA200005727B (en) 2001-02-21
EP1150661A2 (en) 2001-11-07
BR0007997A (pt) 2001-10-30
PT1150661E (pt) 2004-02-27
WO2000045795A3 (en) 2001-08-09
DE60006069D1 (de) 2003-11-27
PL350186A1 (en) 2002-11-18
JP2002536319A (ja) 2002-10-29
HK1042043B (zh) 2004-04-08
IS6035A (is) 2001-08-02
EP1150661B1 (en) 2003-10-22
IL144729A0 (en) 2002-06-30
RO121628B1 (ro) 2008-01-30
CA2359640A1 (en) 2000-08-10
NO20013815L (no) 2001-10-02
DE60006069T2 (de) 2004-07-29
IL144729A (en) 2007-10-31
ATE252380T1 (de) 2003-11-15
WO2000045795A2 (en) 2000-08-10
HUP0105336A3 (en) 2004-06-28
AU2447200A (en) 2000-08-25
HUP0105336A2 (en) 2002-06-29
NO329474B1 (no) 2010-10-25
CA2359640C (en) 2008-11-18
DK1150661T3 (da) 2004-03-01
AU759515B2 (en) 2003-04-17
HK1042043A1 (en) 2002-08-02
ES2209812T3 (es) 2004-07-01
PL196413B1 (pl) 2007-12-31
NO20013815D0 (no) 2001-08-03
ID30353A (id) 2001-11-22

Similar Documents

Publication Publication Date Title
IS2073B (is) Staðbundnir úðar sem innihalda himnumyndandi blöndu
NO2016013I1 (no) Buprenorfin; 21-syklopropyl-7µ-[(S)-1-hydroksy-1,2,3-trimetylpropyl]-6,14-endoetano-6,7,8,14-tetrahydrooripavin
CA2402020A1 (en) Pharmaceutical compositions
JP2009524509A5 (is)
EP1382655A3 (en) A concentrated aerosol space spray
GB0016876D0 (en) Novel formulation
FR2823118B1 (fr) Nouvelle composition filmogene a usage topique et son utilisation pour la delivrance d'agents actifs
AU6882796A (en) Pharmaceutical compositions and devices for their administration
BG107257A (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
AUPO637197A0 (en) Taste-masked pharmaceutical compositions
JPH02290810A (ja) エアゾール製剤
CA2348474A1 (en) Pharmaceutically active composition and dispensing device
NZ547376A (en) Transdermal pharmaceutical spray formulations comprising a VP/VA copolymer and a non-aqueous vehicle
JP2005533795A5 (is)
DK1161225T3 (da) Doseringsaerosol med isobutan som drivmiddel
WO2003070194A3 (en) Amino acid and peptide-modified forms of glucocorticoids
MX9707073A (es) Preparaciones de aerosol de prilocaina e hidrofluorocarbono.